Sample size estimation based on Case and Morgan Two Stage Phase II Design with an expected duration of accrual of 2 years, assuming a power of 80% and a level of significance of 10%. With an S0 of 0.25 and SA of 0.50, an interim analysis will be performed after 14 patients are recruited with an anticipated final recruitment total of 21 patients for each arm of the study.